Strengthen protection against severe RSV (Respiratory Syncytial Virus)—a leading cause of pneumonia and bronchiolitis in young children—with passive immunization.
-
Reduces the risk of RSV infection by up to 79.5%
-
Decreases the risk of hospitalization by 83.2%
-
Reduces the severity of infection requiring mechanical ventilation in the ICU by 75.3%
Suitable for infants from birth up to 2 years old, ensuring safety and good health for your beloved little one.
